<DOC>
	<DOCNO>NCT01343901</DOCNO>
	<brief_summary>This observational study evaluate efficacy safety Avastin ( bevacizumab ) first-line treatment patient colorectal cancer potentially resectable liver metastasis . Data collect patient 36 month .</brief_summary>
	<brief_title>An Observational Study Avastin ( Bevacizumab ) First-Line Treatment Colorectal Cancer Patients With Potentially Resectable Liver Metastases ( PICASSO )</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age Colorectal cancer exclusively hepatic hepatic pulmonary metastasis Firstline treatment Avastin potentially resectable metastatic disease Outright resectable disease Clearly inoperable disease Participation clinical trial evaluate cytotoxic anticancer treatment and/or innovative therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>